-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Imax, Raises Price Target to $46

Benzinga·12/08/2025 14:20:03
Listen to the news
Wedbush analyst Alicia Reese maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $39 to $46.